Get the Stockscreener App
2.58
3.38%
-0.08
60 Degrees Pharmaceuticals Inc stock is traded at $2.58, with a volume of 37,817.
It is down -3.38% in the last 24 hours and down -4.10% over the past month.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
See More
Previous Close:
$2.66
Open:
$2.66
24h Volume:
37,817
Relative Volume:
0.05
Market Cap:
$3.76M
Revenue:
$502.40K
Net Income/Loss:
$-7.91M
P/E Ratio:
-0.2587
EPS:
-9.972
Net Cash Flow:
$-4.32M
1W Performance:
+27.86%
1M Performance:
-4.10%
6M Performance:
-51.51%
1Y Performance:
-85.22%
1-Day Range:
$2.5475
$2.6731
1-Week Range:
$2.0298
$2.74
52-Week Range:
$1.41
$35.99
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Name
60 Degrees Pharmaceuticals Inc
Sector
Industry
Phone
202-327-5422
Address
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
2.56 | 3.32M | 502.40K | -7.91M | -4.32M | -9.972 |
|
ONC
Beone Medicines Ltd Adr
|
246.33 | 25.81B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.61 | 111.46B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.31 | 40.37M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.23 | 6.19B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
492.26 | 64.44B | 14.09B | 4.50B | 2.96B | 39.28 |
60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News
4D Molecular Therapeutics (NASDAQ:FDMT) Receives Sell (E+) Rating from Weiss Ratings - Defense World
Research Analysts’ Recent Ratings Changes for Adaptimmune Therapeutics (ADAP) - Defense World
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Given Sell (E+) Rating at Weiss Ratings - Defense World
Live Radar: Track thunderstorms as they move across Southeast Georgia and Northeast Florida (Video) - Spot On Florida
Pre-market Movers: CMRX, CPIX, PBM, CRVO... - RTTNews
VSee Health Launches AI-Powered Telehealth to Reduce Maternal Deaths in Remote Philippines - Quantisnow
Rakovina Therapeutics Announces Strategic Private Placement, Convertible Debt Financing, and Share Consolidation to Accelerate US-Focused Growth and AI-Powered Oncology Innovation - The Manila Times
60 Degrees Pharmaceuticals, Inc. Reports 55% Increase in Q1 2025 Net Product Revenues to $163.6 Thousand - Nasdaq
60 Degrees Pharmaceuticals Announces First Quarter 2025 Results - The Globe and Mail
60 DEGREES PHARMACEUTICALS, INC. SEC 10-Q Report - TradingView
AST SpaceMobile (ASTS) Expected to Announce Earnings on Wednesday - Defense World
60 Degrees Pharmaceuticals (SXTP) to Release Quarterly Earnings on Wednesday - Defense World
KORE Group (KORE) to Release Quarterly Earnings on Thursday - Defense World
SPAR Group (SGRP) Expected to Announce Earnings on Wednesday - Defense World
Society Pass (SOPA) Projected to Post Quarterly Earnings on Wednesday - Defense World
Windtree Therapeutics (WINT) to Release Earnings on Wednesday - Defense World
Spero Therapeutics (SPRO) to Release Earnings on Wednesday - Defense World
Top Pharmaceutical Stocks To Follow Today – May 9th - Defense World
60 Degrees Pharmaceuticals’ (SXTP) “Sell (E+)” Rating Reaffirmed at Weiss Ratings - Defense World
Spartan Delta Corp. (TSE:SDE) Given Average Recommendation of “Strong Buy” by Analysts - Defense World
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
National Bank Financial Weighs in on TSE:ATD FY2025 Earnings - Defense World
FY2025 EPS Estimates for VERA Decreased by Cantor Fitzgerald - Defense World
Evoke Pharma (EVOK) to Release Earnings on Tuesday - Defense World
Legend Biotech (LEGN) Expected to Announce Earnings on Tuesday - Defense World
Best Green Energy Stocks To Research – May 9th - Defense World
PTC Therapeutics (NASDAQ:PTCT) Raised to Strong-Buy at StockNews.com - Defense World
Denny’s Co. (NASDAQ:DENN) Shares Sold by Barclays PLC - Defense World
Brokerages Set Bright Minds Biosciences Inc. (NASDAQ:DRUG) Target Price at $83.25 - Defense World
Harrow (HROW) Reports Q1 Loss, Lags Revenue Estimates - Nasdaq
Raymond James Financial Inc. Makes New Investment in NETSTREIT Corp. (NYSE:NTST) - Defense World
60 Degrees Pharmaceuticals Announces 2024 Annual Results - ADVFN
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Given “Sell (E+)” Rating at Weiss Ratings - Defense World
60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split - ADVFN
60 Degrees Pharmaceuticals (SXTP) Unveils Discrepancies in Babes - GuruFocus
Daily Progress: 60 Degrees Pharmaceuticals Inc (SXTP) Drop -15.51, Closing at 2.67 - DWinneX
60 Degrees Pharmaceuticals Inc (SXTP) Stock: A Comprehensive 52-Week Review - investchronicle.com
60 Degrees Pharmaceuticals Inc’s latest rating changes from various analysts - knoxdaily.com
How is SXTP’s stock performing after recent trades? - uspostnews.com
Shocking Gap: Survey Finds 3 Million Babesiosis Cases While CDC Reports Only 1,834Major Market Opportunity - Stock Titan
Babesiosis Disease Burden in United States is Substantially Higher Than Official Estimates, According to Preliminary Results of 60 Degrees Pharma Survey - Yahoo Finance
Form 8-KCurrent report - ADVFN
60 Degrees Pharma Announces $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - ADVFN
60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) Short Interest Down 43.2% in March - Defense World
Deal Watch: Oak Hill Picks Up Where Roche Left Off In Angelman Syndrome - insights.citeline.com
Why 60 Degrees Pharmaceuticals, Inc. (SXTP) Went Down On Thursday? - MSN
60 Degrees Pharma's Breakthrough: New Clinical Trials Target Rising Tick-Borne Disease Crisis - Stock Titan
10 Stocks Fall Behind Amid Market Optimism - Insider Monkey
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
60 Degrees Pharmaceuticals’ (SXTP) “Sell (E+)” Rating Reiterated at Weiss Ratings - Defense World
60 Degrees and Yale to progress tafenoquin for babesiosis - Yahoo
60 Degrees Pharmaceuticals Inc Stock (SXTP) Financials Data
Revenue
Net Income
Cash Flow
EPS
60 Degrees Pharmaceuticals Inc Stock (SXTP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| XU CHERYL | Director |
Dec 12 '24 |
Buy |
1.82 |
5,000 |
9,125 |
46,078 |
| XU CHERYL | Director |
Dec 16 '24 |
Buy |
1.45 |
2,000 |
2,900 |
54,078 |
| DOW GEOFFREY S | President and CEO |
Dec 09 '24 |
Buy |
1.27 |
35,823 |
45,563 |
94,580 |
| DOW GEOFFREY S | President and CEO |
Dec 06 '24 |
Buy |
1.20 |
20,579 |
24,672 |
58,757 |
| DOW GEOFFREY S | President and CEO |
Dec 05 '24 |
Buy |
1.11 |
17,549 |
19,520 |
38,178 |
| DOW GEOFFREY S | President and CEO |
Nov 21 '24 |
Buy |
0.91 |
3,500 |
3,195 |
20,629 |
| DOW GEOFFREY S | President and CEO |
Nov 19 '24 |
Buy |
0.90 |
2,500 |
2,248 |
16,129 |
| DOW GEOFFREY S | President and CEO |
Nov 20 '24 |
Buy |
0.92 |
1,000 |
924 |
17,129 |
| XU CHERYL | Director |
Aug 27 '24 |
Buy |
1.70 |
5,000 |
8,500 |
41,078 |
2.38%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):